{"id":"232ab99ce440","type":"article","url":"https://hartvaat.nl/2021/11/09/colchicine-na-acs-2-jaars-cops-follow-up/","title":"Colchicine na ACS: 2-jaars COPS follow-up","title_en":"Colchicine in Patients With Acute Coronary Syndrome: Two-Year Follow-Up of the Australian COPS Randomized Clinical Trial.","category":"algemeen","category_label":"Algemeen","professions":["apotheker","cardioloog"],"tags":[],"journal":"Circulation","doi":"10.1161/CIRCULATIONAHA.121.054610","source_url":"https://doi.org/10.1161/CIRCULATIONAHA.121.054610","authors":["David C Tong","Jason E Bloom","Stephen Quinn","Arthur Nasis","Chin Hiew","Philip Roberts-Thomson","Heath Adams","Rumes Sriamareswaran","Nay M Htun","William Wilson","Dion Stub","William van Gaal","Laurie Howes","Allysha Yeap","Brian Yip","Sam Wu","Padeepa Perera","Nicholas Collins","Andy Yong","Ravinay Bhindi","Robert Whitbourn","Astin Lee","Manuja Premaratne","Kaleab Asrress","Melanie Freeman","John Amerena","Jamie Layland"],"significance":7,"published":"2021-11-09","source_date":"2021-11-09","image":"","kennis":[],"congress":"","summary_en":"The 2-year COPS follow-up of colchicine after ACS showed attenuation of the early mortality signal and a trend toward ischemic benefit, providing longer-term context for the initial concerning safety finding.","created":"2026-07-03T10:29:29Z","updated":"2026-07-03T13:28:37Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"COPS 2-jaarsfollow-up van colchicine na ACS. Langetermijnresultaten na het initiële veiligheidssignaal.","abstract_original":""}